摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

magnesium;2-ethylhexanoate

中文名称
——
中文别名
——
英文名称
magnesium;2-ethylhexanoate
英文别名
——
magnesium;2-ethylhexanoate化学式
CAS
——
化学式
C16H30MgO4
mdl
——
分子量
310.71
InChiKey
CGSNFLLWLBPMLH-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.52
  • 重原子数:
    21
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    80.3
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • Hydrocarbon-Soluble Halogen and Thiolate/Magnesium Exchange Reagents
    申请人:ALBEMARLE GERMANY GMBH
    公开号:US20200239496A1
    公开(公告)日:2020-07-30
    The invention relates to hydrocarbon-soluble halogen or thiolate/magnesium exchange reagents of the general formula R 1 MgR 1 1−n (OR 3 ) n ·LiOR2·(1−n)LiOR 3 ·aDonor in which: R 1 is a C1-C8 alkyl and OR 2 as well as OR 3 are same or different and represent primary, secondary, or tertiary alkoxide residues having 3 to 18 carbon atoms, wherein R 2 and/or R 3 can for their part contain an alkoxy substituent OR 4 ; a assumes a value of 0 to 2, n assumes a value between 0 and 1, and the donor is an organic molecule containing at least 2 nitrogen atoms.
    该发明涉及一般式为R1MgR11−n(OR3)n·LiOR2·(1−n)LiOR3·a供体的烃溶性卤素或醇/交换试剂,其中:R1是C1-C8烷基,OR2和OR3是相同或不同的,表示具有3到18个碳原子的一次、二次或三次烷氧基残基,其中R2和/或R3可以含有烷氧基取代基OR4;a取值0至2,n取值0至1,供体是含有至少2个氮原子的有机分子。
  • [EN] PROCESSES FOR THE PREPARATION OF UNSATURATED ESTERS<br/>[FR] PROCÉDÉS DE PRÉPARATION D'ESTERS INSATURÉS
    申请人:AROMOR FLAVORS & FRAGRANCES LTD
    公开号:WO2015059696A1
    公开(公告)日:2015-04-30
    The invention provides a process for the preparation of alkyl 4-methyl-6-(2,6,6-trimethylcyclohex-lenyl) hex-3-enoate comprising a single step wherein 2-methyl-4-(2,6,6- trimethylcyclohex-l-en-l-yl)butanal is reacted with monoalkyl malonate.
    该发明提供了一种制备烷基4-甲基-6-(2,6,6-三甲基环己烯基)己-3-烯酸酯的方法,包括一步反应,其中2-甲基-4-(2,6,6-三甲基环己-1-烯-1-基)丁醛与单烷基丙二酸酯发生反应。
  • Process for solvent removal from omeprazole salts
    申请人:LEK Pharmaceuticals d.d.
    公开号:EP1947099A1
    公开(公告)日:2008-07-23
    The present invention relates to a process for removing an organic solvent from a salt of omeprazole, in particular a magnesium salt of omeprazole, a composition comprising a salt of omeprazole, in particular a magnesium salt of omeprazole obtainable by such a process, and pharmaceutical compositions comprising said composition or a salt of omeprazole, in particular a magnesium salt of omeprazole, in particular where omeprazole is S-omeprazole..
    本发明涉及一种从奥美拉唑的盐中去除有机溶剂的方法,特别是从奥美拉唑盐中去除有机溶剂的方法,包括一种奥美拉唑的盐,特别是通过这种方法获得的奥美拉唑盐,以及包含所述组合物或奥美拉唑的盐的药物组合物,特别是奥美拉唑为S-奥美拉唑
  • S-omeprazole magnesium
    申请人:Savanovic Vranicar Lidija
    公开号:US20070149573A1
    公开(公告)日:2007-06-28
    The present invention discloses a process for preparing a magnesium salt of S-omeprazole. The S-omeprazole salt preferably has a water content below about 4.8% by weight, a magnesium content of about 3.4-4.0% by weight, calculated on the weight of anhydrous, solvent free S-omeprazole magnesium, and has an optical purity of at least about 85% entantiomeric excess (“e.e.”). In addition, the present invention provides a magnesium salt of S-omeprazole which is substantially free of neutral omeprazole, meaning that the product contains less than about 3% by weight of a-sum of neutral S-omeprazole and neutral omeprazole. Moreover, the S-omeprazole magnesium according to the invention preferably has assay of related substances and degradation products of less than about 0.1 % by weight as determined by high performance liquid chromatography (HPLC).
    本发明揭示了一种制备S-奥美拉唑盐的过程。S-奥美拉唑盐的含量最好低于约4.8%的重量,含量约为3.4-4.0%的重量,以无、无溶剂的S-奥美拉唑为基础计算,其光学纯度至少为约85%的对映体过量(“e.e.”)。此外,本发明提供了一种S-奥美拉唑盐,该盐基本上不含中性奥美拉唑,也就是产品中少于约3%的重量是中性S-奥美拉唑和中性奥美拉唑的总和。此外,根据本发明,S-奥美拉唑最好具有相关物质和降解产物的测定值小于约0.1%的重量,由高效液相色谱法(HPLC)确定。
  • Use of improved cyan pigments in electrophotographic toners and developers, powder coatings and inkjet inks
    申请人:——
    公开号:US20020062763A1
    公开(公告)日:2002-05-30
    The present invention relates to the use of a CuPc composition consisting essentially of CuPc, e.g., C.I. Pigment Blue 15:3, and a hydroxymethylphthalimido CuPc, as a colorant in electrophotographic toners and developers, powders and powder coating materials, electret materials, inkjet inks, and color filters, wherein the phthalocyanines have a particle morphology with an average length-to-width ratio of more than 2.5:1.
    本发明涉及使用由CuPc组成的组合物,例如C.I. Pigment Blue 15:3和羟甲基邻苯二酰亚胺基CuPc,作为静电复印机色调剂、开发剂、粉末和粉末涂料材料、静电材料、喷墨墨和彩色滤光片的染料,其中酞菁类具有平均长度与宽度比大于2.5:1的颗粒形态。
查看更多